- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.11. | Simris Group AB receives observation status | 78 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 12.11. | Simris Group AB: Simris Group Interim Report January-september 2025 | 81 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11. | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 111 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11. | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 105 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10. | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 170 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09. | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 805 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08. | Simris Group AB: Simris Group Interim Report January-june 2025 | 161 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07. | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 147 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| 28.05. | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 277 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05. | Simris Group AB: Simris Group Interim Report January-march 2025 | 328 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen | |
| 26.02. | Simris Group AB: Simris Group Year-end Report January-december 2024 | 202 | GlobeNewswire (Europe) | QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK... ► Artikel lesen | |
| 04.02. | The observation status for Simris Group AB is removed | 311 | GlobeNewswire | On October 24, 2024, the shares in Simris Group AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,850 | -0,65 % | Spekulanten greifen an: Billig-Calls katapultieren Beyond Meat 20% nach oben | © Foto: Gene J. Puskar - APEine Flut billiger Call-Wetten hat den nächsten Zock um Beyond Meat ausgelöst. Die Aktie steigt zweistellig - trotz Millionenstrafe, Umsatzrückgang und anhaltender Krise.Die... ► Artikel lesen | |
| OATLY GROUP | 10,550 | -0,94 % | Nach einer langen Durststrecke stellt Oatly wieder Gewinne in Aussicht und auch die Aktie schlägt sich wieder besser | Nur etwas mehr als vier Jahre liegt der Börsengang von Oatly zurück, der von viel Euphorie begleitet wurde. Der Aktienkurs schoss zeitweise auf mehr als 500 US-Dollar in die Höhe und nach oben schien... ► Artikel lesen | |
| CONAGRA BRANDS | 15,470 | +0,52 % | Research and Markets: United Kingdom Diabetic Food Market Forecast and Company Analysis Report 2025-2033 Featuring Nestle, Unilever, Kellogg Co, Conagra Brands, Tyson Foods, Hershey Co, Hain Celestial - ResearchAndMarkets.com | The "United Kingdom Diabetic Food Market Report by Products, Distribution Channel, Region and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The United... ► Artikel lesen | |
| AGRARIUS | - | - | Agrarius AG: "Konzernjahresfehlbetrag sinkt von 2,37 auf 1,98 Mio. Euro - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | - im Anhang finden Sie den HV-Bericht von GSC-Research.Anhang: HVAGRARIUS2025.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 230,00 | +0,88 % | Wingstop's explosive growth continues -- just not its share price | ||
| WH GROUP | 0,905 | +1,69 % | Dividendenbekanntmachungen (06.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPANHIA ENERGETICA DE MINAS GERAIS-CEM ... US2044096012 0,0397 USD 0,0338 EUR COMPANHIA ENERGETICA DE MINAS GERAIS-CEM ... US2044098828 0... ► Artikel lesen | |
| ELSE NUTRITION | 0,120 | -7,53 % | Stocks in Play: Else Nutrition Holdings Inc. | ||
| MHP | 4,880 | -5,24 % | MHP has successfully closed the transaction to acquire over 92% stake in Grupo UVESA | KYIV, Ukraine, Aug. 4, 2025 /PRNewswire/ -- MHP, a leading international food and agri company, has officially closed the transaction to acquire over 92% of the share capital of Grupo UVESA... ► Artikel lesen | |
| BIOGAIA | 9,260 | +0,43 % | BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production | Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system)... ► Artikel lesen | |
| JACK IN THE BOX | 16,500 | -2,94 % | Here's What is Affected Jack in the Box's (JACK) Growth Plans | ||
| J&J SNACK FOODS | 78,50 | -0,63 % | J&J SNACK FOODS CORP - 10-K, Annual Report | ||
| KATJES | 104,00 | 0,00 % | Katjes Group 'in talks to buy Graze from Unilever' | ||
| FIRST WATCH RESTAURANT GROUP | 18,560 | +0,60 % | First Watch Restaurant Group, Inc. Reports Q2 2025 Financial Results and Reaches 600th System-Wide Restaurant Milestone | Total revenues increased 19.1%Net income of $2.1 million and Adjusted EBITDA of $30.4 million17 new system-wide restaurants opened in 8 statesRaising 2025 Adjusted EBITDA guidance BRADENTON, Fla.... ► Artikel lesen | |
| ABOVE FOOD INGREDIENTS | 3,000 | +14,07 % | Above Food Ingredients Inc. Announces Major Strategic Milestones, Merger Advancement with Palm Global, and Expected Profit Exceeding $30 Million for Fiscal Year Ended January 31, 2026 | REGINA, SK, Nov. 28, 2025 /PRNewswire/ - Above Food Ingredients Inc. (NASDAQ: ABVE) ("Above Food" or the "Company") is pleased to provide shareholders with a significant... ► Artikel lesen | |
| CAVA GROUP | 48,860 | -1,63 % | CAVA or CMG: Which Fast-Casual Stock Looks Stronger Right Now? |
SIMRIS GROUP AB gehört der Branche Nahrungsmittel/Agrar an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,009 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMRIS GROUP AB finden Sie auf Wallstreet Online.